BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

592 related articles for article (PubMed ID: 16336203)

  • 21. Restricted transgene persistence after lentiviral vector-mediated fetal gene transfer in the pregnant rabbit model.
    Moreno R; Rosal M; Martinez I; Vilardell F; Gonzalez JR; Petriz J; Hernandez-Andrade E; Gratacós E; Aran JM
    J Gene Med; 2008 Sep; 10(9):951-64. PubMed ID: 18613266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lentiviral vector-mediated gene delivery into human embryonic stem cells.
    Gropp M; Reubinoff B
    Methods Enzymol; 2006; 420():64-81. PubMed ID: 17161694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene therapy in ocular diseases.
    Singh VK; Tripathi P
    Indian J Ophthalmol; 2002 Sep; 50(3):173-81. PubMed ID: 12355690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene therapy in the CNS.
    Costantini LC; Bakowska JC; Breakefield XO; Isacson O
    Gene Ther; 2000 Jan; 7(2):93-109. PubMed ID: 10673714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene therapeutic strategies for neurodegenerative diseases.
    Baekelandt V; De Strooper B; Nuttin B; Debyser Z
    Curr Opin Mol Ther; 2000 Oct; 2(5):540-54. PubMed ID: 11249757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene therapy progress and prospects: development of improved lentiviral and retroviral vectors--design, biosafety, and production.
    Sinn PL; Sauter SL; McCray PB
    Gene Ther; 2005 Jul; 12(14):1089-98. PubMed ID: 16003340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of gene therapy for hematopoietic stem cell using viral vectors].
    Dong WJ; Zu ZX; Liu DP; Liang CC
    Yi Chuan Xue Bao; 2003 Apr; 30(4):382-8. PubMed ID: 12812066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-viral ocular gene therapy: potential ocular therapeutic avenues.
    Bloquel C; Bourges JL; Touchard E; Berdugo M; BenEzra D; Behar-Cohen F
    Adv Drug Deliv Rev; 2006 Nov; 58(11):1224-42. PubMed ID: 17095114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
    Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
    Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A roadmap to safe, efficient, and stable lentivirus-mediated gene therapy with hematopoietic cell transplantation.
    Neschadim A; McCart JA; Keating A; Medin JA
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1407-16. PubMed ID: 18022569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HIV-2 derived lentiviral vectors: gene transfer in Parkinson's and Fabry disease models in vitro.
    D'Costa J; Harvey-White J; Qasba P; Limaye A; Kaneski CR; Davis-Warren A; Brady RO; Bankiewicz KS; Major EO; Arya SK
    J Med Virol; 2003 Oct; 71(2):173-82. PubMed ID: 12938190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lentiviral vector delivery of recombinant small interfering RNA expression cassettes.
    Li MJ; Rossi JJ
    Methods Enzymol; 2005; 392():218-26. PubMed ID: 15644184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene transfer system derived from the caprine arthritis-encephalitis lentivirus.
    Mselli-Lakhal L; Guiguen F; Greenland T; Mornex JF; Chebloune Y
    J Virol Methods; 2006 Sep; 136(1-2):177-84. PubMed ID: 16797087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stable and efficient intraocular gene transfer using pseudotyped EIAV lentiviral vectors.
    Balaggan KS; Binley K; Esapa M; Iqball S; Askham Z; Kan O; Tschernutter M; Bainbridge JW; Naylor S; Ali RR
    J Gene Med; 2006 Mar; 8(3):275-85. PubMed ID: 16299834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lentiviruses in gene therapy clinical research.
    Connolly JB
    Gene Ther; 2002 Dec; 9(24):1730-4. PubMed ID: 12457288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simian immunodeficiency virus-based lentivirus vector for retinal gene transfer: a preclinical safety study in adult rats.
    Ikeda Y; Goto Y; Yonemitsu Y; Miyazaki M; Sakamoto T; Ishibashi T; Tabata T; Ueda Y; Hasegawa M; Tobimatsu S; Sueishi K
    Gene Ther; 2003 Jul; 10(14):1161-9. PubMed ID: 12833125
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.
    Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J
    Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Murine and HIV-based retroviral vectors for in vitro and in vivo gene transfer.
    Alfa RW; Blesch A
    Methods Mol Med; 2006; 129():241-54. PubMed ID: 17085815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Progress toward the genetic treatment of the beta-thalassemias.
    Sadelain M; Lisowski L; Samakoglu S; Rivella S; May C; Riviere I
    Ann N Y Acad Sci; 2005; 1054():78-91. PubMed ID: 16339654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentiviral vectors for use in the central nervous system.
    Jakobsson J; Lundberg C
    Mol Ther; 2006 Mar; 13(3):484-93. PubMed ID: 16403676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.